Our results suggested that PLGA-PEG-B6/Cur nanoparticles could improve learning and memory function and ameliorate AD pathologies by reducing tau phosphorylation and Aβ deposition, in which alteration of APP and β-secretase cleavage processing might be involved. The gene discussed is MAPT; the disease is Alzheimer disease.